ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 487,800 shares, a decline of 33.1% from the March 31st total of 729,300 shares. Based on an average daily volume of 520,900 shares, the short-interest ratio […]
ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) and Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Profitability This table compares ReShape Lifesciences and […]
ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) saw a significant increase in short interest in August. As of August 31st, there was short interest totalling 36,400 shares, an increase of 658.3% from the August 15th total of 4,800 shares. Based on an average daily volume of 160,200 shares, the days-to-cover ratio is currently 0.2 […]
ReShape Lifesciences Inc. (NASDAQ:RSLS – Free Report) CFO Thomas Stankovich bought 17,702 shares of ReShape Lifesciences stock in a transaction dated Friday, June 30th. The shares were purchased at an average cost of $1.52 per share, for a total transaction of $26,907.04. Following the completion of the transaction, the chief financial officer now owns 23,490 […]
ReShape Lifesciences Inc. (NASDAQ:RSLS – Free Report) saw a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 41,700 shares, a decrease of 59.6% from the May 31st total of 103,100 shares. Currently, 1.5% of the company’s shares are sold short. Based on an average […]